In August 2025, a subject in the high-dose group of Huida Gene's HG302 Duchenne muscular dystrophy gene editing clinical trial died from a severe immune reaction triggered by AAV, and the incident was not disclosed until about a year later.
Evidence EVIDENCE
Sources 2 · Archived 0
SourceTypeReliabilityLink
老北京茶館 - 幽默時政
2026-09-24 07:34 · 老北京茶館 - 幽默時政 发布了新视频：北戴河會議中途，胡錦濤王岐山突“露面”？習近平動手搶香港保險錢了！上三休四沒工資，兩名中國嬰兒被基因編輯奪命！（老北京茶館/第1709集/2026/08/08）
Media
●●●●●
虎嗅：辉大基因HG302
2026-10-07 01:17 · 辉大基因针对杜氏肌营养不良的在研基因编辑治疗HG302开展IIT临床试验，2025年8月确认一名高剂量组受试者因AAV诱发严重免疫反应死亡
Web Source
●●●●●
Context CONTEXT
Cause
Not recorded yet
This event
Child Subject Dies in Gene Editing Clinical Trial Developed by Huida Gene
2025.08 · Reported
Effect
Not recorded yet
Coverage of this event COVERAGE